Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gastrointestinal 1Dermatologic 1Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 1865Lung Neoplasms 1300Small Cell Lung Carcinoma 327Colorectal Neoplasms 275Breast Neoplasms 244Melanoma 222Neoplasms 214Ovarian Neoplasms 192Neoplasm Metastasis 184Pancreatic Neoplasms 155Squamous Cell Carcinoma of Head and Neck 150Stomach Neoplasms 141Head and Neck Neoplasms 122Carcinoma, Renal Cell 120Triple Negative Breast Neoplasms 109Prostatic Neoplasms 107Esophageal Neoplasms 107Endometrial Neoplasms 98Uterine Cervical Neoplasms 96Urinary Bladder Neoplasms 88Colonic Neoplasms 87Mesothelioma 86Mesothelioma, Malignant 80Carcinoma, Hepatocellular 75Brain Neoplasms 71Sarcoma 63Disease 62Adenocarcinoma of Lung 60Carcinoma, Transitional Cell 54Gastrointestinal Neoplasms 50

Interventions

pembrolizumab 1omega-N-Methylarginine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
DNA Repair-Deficiency Disorders × Thoracic × 1 year × Clear all
NCT03236935 2026-04-09

Phase Ib of L-NMMA and Pembrolizumab

The Methodist Hospital Research Institute

Phase 1 Completed
12 enrolled 15 charts
DermatologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, DNA Repair-Deficiency Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡